EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Potential Contribution of Cell Adhesion Molecule 1 to the Binding of SARS-CoV-2 Spike Protein to Mouse Nasal Mucosa

Fuka Takeuchi, Aki Sugano, Azusa Yoneshige, Man Hagiyama, Takao Inoue, Akihiro Wada, Yutaka Takaoka, Akihiko Ito

Cells Tissues Organs · 2024

DOI: 10.1159/000534892 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells Tissues Organs, 2024. Verfasst von Fuka Takeuchi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Kindai University Faculty of Medicine, Osaka-sayama, Japan, 2145060003@edu.med.kindai.ac.jp. Hauptthemen laut MEDLINE: Spike Glycoprotein, Coronavirus, Angiotensin-Converting Enzyme 2, SARS-CoV-2, Cell Adhesion Molecule-1. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) first infects the host nasal mucosa, where the viral spike protein binds to angiotensin-converting enzyme 2 (ACE2) on the mucosal cells. This study aimed at searching host cell surface molecules that could contribute to the infection in two views; abundance on host cells and affinity to the spike protein. Since the nasal mucosa is lined by respiratory and olfactory epithelia, and both express an immunoglobulin superfamily member cell adhesion molecule 1 (CADM1), whether CADM1 would participate in the spike protein binding was examined. Immunohistochemistry on the mouse nasal cavity detected CADM1 strongly in the olfactory epithelium at cell-cell contacts and on the apical surface but just faintly in the respiratory epithelium. In contrast, ACE2 was detected in the respiratory, not olfactory, epithelium. When mice were administered intranasally with SARS-CoV-2 S1 spike protein and an anti-CADM1 ectodomain antibody separately, both were detected exclusively on the olfactory, not respiratory, epithelium. Then, the antibody and S1 spike protein were administered intranasally to mice in this order with an interval of 1 h. After 3 h, S1 spike protein was detected as a protein aggregate floating in the nasal cavity. Next, S1 spike protein labeled with fluorescein was added to the monolayer cultures of epithelial cells exogenously expressing ACE2 or CADM1. Quantitative detection of fluorescein bound to the cells revealed that S1 spike protein bound to CADM1 with affinity half as high as to ACE2. Consistently, docking simulation analyses revealed that S1 spike protein could bind to CADM1 three-quarters as strongly as to ACE2 and that the interface of ACE2 was similar in both binding modes. Collectively, intranasal S1 spike protein appeared to prefer to accumulate on the olfactory epithelium, and CADM1 was suggested to contribute to this preference of S1 spike protein based on the molecular abundance and affinity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spike Glycoprotein, CoronavirusAngiotensin-Converting Enzyme 2SARS-CoV-2Cell Adhesion Molecule-1Nasal MucosaProtein BindingCOVID-19AnimalsMiceHumansPeptidyl-Dipeptidase AFemale

Stichwörter der Autor:innen

COVID-19 preventionCell adhesion molecule 1Docking simulationOlfactory epitheliumSARS-CoV-2 spike protein

Substanzen

Spike Glycoprotein, Coronavirusspike protein, SARS-CoV-2Angiotensin-Converting Enzyme 2Cell Adhesion Molecule-1Cadm1 protein, mouseAce2 protein, mouseACE2 protein, humanPeptidyl-Dipeptidase A

Autor:innen und Institutionen

  • Department of Pathology, Kindai University Faculty of Medicine, Osaka-sayama, Japan, 2145060003@edu.med.kindai.ac.jp.
  • Center for Clinical Research, Toyama University Hospital, Toyama, Japan.
  • Data Science Center for Medicine and Hospital Management, Toyama University Hospital, Toyama, Japan.
  • Department of Medical Systems, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Department of Pathology, Kindai University Faculty of Medicine, Osaka-sayama, Japan.

Zitieren

APA

Takeuchi, F., Sugano, A., Yoneshige, A., Hagiyama, M., Inoue, T., Wada, A., Takaoka, Y., & Ito, A. (2024). Potential Contribution of Cell Adhesion Molecule 1 to the Binding of SARS-CoV-2 Spike Protein to Mouse Nasal Mucosa. Cells Tissues Organs. https://doi.org/10.1159/000534892

Vancouver

Takeuchi F, Sugano A, Yoneshige A, Hagiyama M, Inoue T, Wada A, et al. Potential Contribution of Cell Adhesion Molecule 1 to the Binding of SARS-CoV-2 Spike Protein to Mouse Nasal Mucosa. Cells Tissues Organs. 2024. doi:10.1159/000534892

BibTeX
@article{Takeuchi2024,
  author = {Takeuchi, Fuka and Sugano, Aki and Yoneshige, Azusa and Hagiyama, Man and Inoue, Takao and Wada, Akihiro and Takaoka, Yutaka and Ito, Akihiko},
  title = {Potential Contribution of Cell Adhesion Molecule 1 to the Binding of SARS-CoV-2 Spike Protein to Mouse Nasal Mucosa},
  journal = {Cells Tissues Organs},
  year = {2024},
  doi = {10.1159/000534892}
}
Kostenlos starten →